RxDoctor Payments Data

Jasen Gilge, MD

Clinical Cardiac Electrophysiology · Indianapolis, INNPI 1306188602

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (33.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Medtronic at 57.1% of the total. Reporting peaked in 2020 at $21,679 and has fallen 81.1% since, to $4,093 in 2025. Among clinical cardiac electrophysiology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$92,708in general payments, 2019–2025

Across 305 payments — averaging $303.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$53K
  • Abbott$28K
  • Boston Scientific$7K
  • Medical Device Business Services, Inc.$3K
  • Biosense Webster, Inc.$881
  • Impulse Dynamics (USA) Inc.$494
  • plus $733 from 4 others
$35,742in research payments, 2019–2025

Across 25 payments — averaging $1429.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$36K

What the payments were for

  • Consulting fees$14,23815%
  • Speaking & faculty fees$11,17512%
  • Grants$31,34134%
  • Travel & lodging$18,53320%
  • Food & beverage$17,18019%
  • Education$2410%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$92,708 in reported general payments places this provider in the 90th percentile of 72 clinical cardiac electrophysiology providers in Indiana.

See all clinical cardiac electrophysiology providers in Indiana

Medicare billing

Part B allowed, 2024
$269,619
Medicare patients
619
Services billed
3,448

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban377$472,307
XareltoRivaroxaban107$130,219
EntrestoSacubitril/Valsartan38$61,633
MultaqDronedarone Hcl29$41,096
Flecainide Acetate101$5,079
Dofetilide47$4,976
Mexiletine Hcl28$4,037
Metoprolol Succinate269$3,453
Amiodarone Hcl118$3,364
Diltiazem 24hr Er (Cd)Diltiazem Hcl83$1,651
SotalolSotalol Hcl99$1,631
Warfarin Sodium78$1,193
Propafenone Hcl25$1,129
Atorvastatin Calcium74$797
ClopidogrelClopidogrel Bisulfate57$671

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →